In-vivo capabilities
Pharmaseed designs and runs custom in vivo studies to advance research across neuroscience, oncology, inflammation and immunology, cardiovascular, metabolic, and other disease areas. Our services span from GLP-compliant toxicology to flexible non-GLP efficacy and pharmacology.
Disease Models
Tumor models to assess efficacy and safety of novel cancer therapies.
Models for Alzheimer’s, Parkinson’s, multiple sclerosis, and other neurological disorders.
Models for diabetes, obesity, and other metabolic disorders.
Infectious Disease & Microbiome
Models to study infectious diseases and the microbiome, including antibiotic and antimicrobial efficacy.
Models of vascular dysfunction: atherosclerosis, ischemia-reperfusion injury, hypertension, and vascular smooth muscle dysfunction.
Ocular models for age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and dry eye disease.
Models for autoimmune and allergic diseases, inflammatory skin conditions, and sepsis, to assess immune modulation and mechanism of action.
Aging models to evaluate interventions for healthy aging and lifespan extension, including dietary restriction, rapamycin, and telomere-length studies.
Working in a different disease area?
Tell us about your study – we likely have relevant experience.
Specialized capabilities:
- Advanced Microsurgery
- Molecular Analysis
- High-End Imaging
- Behavioral Testing
